Detalhe da pesquisa
1.
Test trial of spike-in immunoglobulin heavy-chain (IGH) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia.
Br J Haematol
; 189(4): e150-e154, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187384